Grant: Fellowship: Canada Impact+ Research Training Awards - Postdoctoral
University of Toronto
$140,000.00
Chemical modification of mRNA for enhancing RNA therapeutics
EF 2025-26
Résumé
"Messenger RNA (mRNA) therapies, such as some COVID-19 vaccines, have shown promise for treating many diseases. But today’s mRNA medicines still face real challenges. They can break down quickly in the body, sometimes trigger unwanted immune reactions, and may start working in places where they shouldn’t. All of this limits how effective and safe they can be.
My research focuses on creating a new kind of mRNA that is safer, more stable, and only turns “on” when it reaches the right cells. To make this possible, I plan to add small, removable chemical “locks” to the mRNA. These keep mRNA turned off during delivery so it doesn’t produce proteins at the wrong time. Once the mRNA encounters specific natural molecules inside target tissues, the locks are removed and the mRNA becomes active.
This project also takes advantage of both major types of mRNA. Linear mRNA can be fragile but good at producing proteins, and circular mRNA that lasts longer in the body and is less likely to activate an immune response. I will combine the strengths of both by temporarily turning linear mRNA into a circular form using reversible chemical links. In this temporary circular form, the mRNA stays protected and inactive. When the chemical lock is opened, the mRNA returns to its normal shape and begins working as intended. This research has three goals:
1. Create the chemical “locks” that control when the mRNA becomes active;
2. Test how these locks affect the stability and performance of the mRNA; and
3. Explore how the technology can be used in different biological systems.
This work could lead to new, safer, and more precise mRNA-based treatments"
Programme
Fellowship: Canada Impact+ Research Training Awards - Postdoctoral
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
568100
Name
Huang Congcong
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Postdoctoral
Projecttitle
Chemical modification of mRNA for enhancing RNA therapeutics
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Fellowship: Canada Impact+ Research Training Awards - Postdoctoral
Keyworddelim
Chemical Modification; Mrna Therapy; Stimulus Response
Abstract
"Messenger RNA (mRNA) therapies, such as some COVID-19 vaccines, have shown promise for treating many diseases. But today’s mRNA medicines still face real challenges. They can break down quickly in the body, sometimes trigger unwanted immune reactions, and may start working in places where they shouldn’t. All of this limits how effective and safe they can be.
My research focuses on creating a new kind of mRNA that is safer, more stable, and only turns “on” when it reaches the right cells. To make this possible, I plan to add small, removable chemical “locks” to the mRNA. These keep mRNA turned off during delivery so it doesn’t produce proteins at the wrong time. Once the mRNA encounters specific natural molecules inside target tissues, the locks are removed and the mRNA becomes active.
This project also takes advantage of both major types of mRNA. Linear mRNA can be fragile but good at producing proteins, and circular mRNA that lasts longer in the body and is less likely to activate an immune response. I will combine the strengths of both by temporarily turning linear mRNA into a circular form using reversible chemical links. In this temporary circular form, the mRNA stays protected and inactive. When the chemical lock is opened, the mRNA returns to its normal shape and begins working as intended. This research has three goals:
1. Create the chemical “locks” that control when the mRNA becomes active;
2. Test how these locks affect the stability and performance of the mRNA; and
3. Explore how the technology can be used in different biological systems.
This work could lead to new, safer, and more precise mRNA-based treatments"
Competitiondate
202603
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Huang, Congcong
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~